Tarceva (erlotinib)

DRUG2 trials

Sponsors

Weill Medical College of Cornell University, Grupo Gallego de Cancer de Pulmon

Conditions

Carcinoma, Non-small Cell LungNon-Small Cell Lung Cancer

Phase 2

Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer

CompletedNCT00385996

Weill Medical College of Cornell UniversityCarcinoma, Non-small Cell Lung

Start: 2006-10-31End: 2011-08-31Updated: 2018-12-28

Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer

Grupo Gallego de Cancer de PulmonNon-Small Cell Lung Cancer

Start: 2006-01-31Target: 46Updated: 2007-04-27